Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Dr. Ran Reshef
Phone
212-342-0530
Email
rr3036@columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Reshef:
More InfoTitleSponsorIRB Number
DetailsA study for patients with lymphomas using EBV-Cytotoxic T Lymphocytes (EBV-CTLs)AtaraAAAR0039
DetailsA study for patients with acute graft host disease (GVHD) following bone marrow transplant using study drug NatalizumabJohn E. LevineAAAQ8173
DetailsA study for patients with chronic Graft Versus Host Disease (cGVHD) using study drug IbrutinibPharmacyclics LLC.AAAR1134